• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缅因州一项甲胎蛋白初步筛查项目的数据。

Data from an alpha-fetoprotein pilot screening program in Maine.

作者信息

Haddow J E, Kloza E M, Smith D E, Knight G J

出版信息

Obstet Gynecol. 1983 Nov;62(5):556-60.

PMID:6194484
Abstract

In Maine, maternal serum alpha-fetoprotein (AFP) values equaled 2 or more multiples of the median in 4.8% of screened women. Between 2.0 and 2.9 multiples of the median repeat maternal serum AFP testing and sonography were comparable as the next diagnostic step; at 3 multiples of the median or higher sonography was superior. Sonography moved dates back in only ten singleton viable pregnancies with maternal serum AFP elevations; three of these had open fetal defects. Among singletons, all five anencephaly cases, one of two open spina bifida lesions, and all three open ventral wall defects were identified. Three closed singleton neural tube defects and two open spina bifida defects in twins were not detected. Nineteen of 36 multiple gestations had maternal serum AFP 2 or higher multiples of the median. In singletons, maternal serum AFP of 3 or higher multiples of the median indicated a thirtyfold increased risk for fetal death and a sevenfold increased risk for birth weight under 2500 g.

摘要

在缅因州,4.8%接受筛查的孕妇血清甲胎蛋白(AFP)值等于或超过中位数的2倍。在中位数的2.0至2.9倍之间,重复进行孕妇血清AFP检测和超声检查作为下一步诊断措施的效果相当;在中位数的3倍或更高时,超声检查更具优势。超声检查仅在10例单胎活产且孕妇血清AFP升高的妊娠中使孕周提前;其中3例存在开放性胎儿缺陷。在单胎妊娠中,所有5例无脑儿病例、2例开放性脊柱裂病变中的1例以及所有3例开放性腹壁缺陷均被检出。3例闭合性单胎神经管缺陷和2例双胎开放性脊柱裂缺陷未被检测到。36例多胎妊娠中有19例孕妇血清AFP为中位数的2倍或更高。在单胎妊娠中,孕妇血清AFP为中位数的3倍或更高表明胎儿死亡风险增加30倍,出生体重低于2500g的风险增加7倍。

相似文献

1
Data from an alpha-fetoprotein pilot screening program in Maine.缅因州一项甲胎蛋白初步筛查项目的数据。
Obstet Gynecol. 1983 Nov;62(5):556-60.
2
Prenatal diagnosis of neural tube defects. IV. Maternal serum alpha-fetoprotein screening.神经管缺陷的产前诊断。IV. 孕妇血清甲胎蛋白筛查。
Obstet Gynecol. 1980 Jan;55(1):60-6.
3
[Increased AFP in maternal serum as an indication for invasive diagnosis].[孕妇血清甲胎蛋白升高作为侵入性诊断的指征]
Zentralbl Gynakol. 1997;119(11):560-6.
4
[Prenatal detection of open neural tube defects in a mass screening program by determination of alpha-fetoprotein concentration in maternal serum].
Zentralbl Gynakol. 1988;110(3):158-67.
5
[Prenatal diagnosis of congenital defects through the determination of alpha fetoprotein].通过甲胎蛋白测定进行先天性缺陷的产前诊断
Fortschr Med. 1979 Jun 7;97(21):1005-8.
6
Elevated maternal serum alpha-fetoprotein and amniotic fluid alpha-fetoprotein after multifetal pregnancy reduction.多胎妊娠减胎术后母血清甲胎蛋白及羊水甲胎蛋白升高。
Obstet Gynecol. 1990 Dec;76(6):1042-5.
7
Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects.孕早期产前筛查无脑儿和脊柱裂时母体血清甲胎蛋白测定。英国甲胎蛋白与神经管缺陷相关协作研究报告。
Lancet. 1977 Jun 25;1(8026):1323-32.
8
Pregnancy outcomes after increasing maternal serum alpha-fetoprotein levels.
Obstet Gynecol. 1989 Jul;74(1):17-20.
9
Maternal serum alpha-fetoprotein screening: benefits, risks, and costs.孕妇血清甲胎蛋白筛查:益处、风险及成本。
J Fam Pract. 1987 Nov;25(5):461-7.
10
Maternal serum screening for birth defects: results of a Connecticut regional program.孕产妇血清出生缺陷筛查:康涅狄格州区域项目的结果
Conn Med. 1996 Jun;60(6):323-7.

引用本文的文献

1
Pregnancy associated plasma protein-A2: a novel biomarker for Down syndrome.妊娠相关血浆蛋白-A2:一种用于唐氏综合征的新型生物标志物。
Placenta. 2014 Nov;35(11):900-6. doi: 10.1016/j.placenta.2014.08.001. Epub 2014 Aug 12.
2
Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis.使用唐氏综合征标志物进行血清筛查以预测子痫前期和小于胎龄儿:系统评价和荟萃分析。
BMC Pregnancy Childbirth. 2008 Aug 4;8:33. doi: 10.1186/1471-2393-8-33.
3
Maternal serum alpha-fetoprotein screening for neural tube defects. Report of a combined study in Germany and short overview on screening in populations with low birth prevalence of neural tube defects.
用于神经管缺陷的母血清甲胎蛋白筛查。德国一项联合研究的报告及神经管缺陷低出生患病率人群筛查的简短概述。
Hum Genet. 1985;69(1):47-61. doi: 10.1007/BF00295529.
4
Maternal serum alpha-fetoprotein screening: report of a Canadian pilot project.孕妇血清甲胎蛋白筛查:加拿大试点项目报告。
CMAJ. 1987 Aug 15;137(4):285-93.